189 related articles for article (PubMed ID: 20144907)
1. Comparison of preservative-induced toxicity on monolayer and stratified Chang conjunctival cells.
Yanochko GM; Khoh-Reiter S; Evans MG; Jessen BA
Toxicol In Vitro; 2010 Jun; 24(4):1324-31. PubMed ID: 20144907
[TBL] [Abstract][Full Text] [Related]
2. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo.
Pellinen P; Huhtala A; Tolonen A; Lokkila J; Mäenpää J; Uusitalo H
Curr Eye Res; 2012 Feb; 37(2):145-54. PubMed ID: 22049909
[TBL] [Abstract][Full Text] [Related]
3. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
[TBL] [Abstract][Full Text] [Related]
4. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells.
De Saint Jean M; Brignole F; Bringuier AF; Bauchet A; Feldmann G; Baudouin C
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):619-30. PubMed ID: 10067965
[TBL] [Abstract][Full Text] [Related]
5. [Toxicity of preserved and unpreserved beta-blocker eyedrops in an in vitro model of human conjunctival cells].
de Saint Jean M; Debbasch C; Brignole F; Rat P; Warnet JM; Baudouin C
J Fr Ophtalmol; 2000 Feb; 23(2):111-21. PubMed ID: 10705112
[TBL] [Abstract][Full Text] [Related]
6. In vitro effects of preservatives in nasal sprays on human nasal epithelial cells.
Ho CY; Wu MC; Lan MY; Tan CT; Yang AH
Am J Rhinol; 2008; 22(2):125-9. PubMed ID: 18416966
[TBL] [Abstract][Full Text] [Related]
7. Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells.
Epstein SP; Ahdoot M; Marcus E; Asbell PA
J Ocul Pharmacol Ther; 2009 Apr; 25(2):113-9. PubMed ID: 19284328
[TBL] [Abstract][Full Text] [Related]
8. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells.
Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2444-50. PubMed ID: 15980234
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells.
Ayaki M; Yaguchi S; Iwasawa A; Koide R
Clin Exp Ophthalmol; 2008 Aug; 36(6):553-9. PubMed ID: 18954319
[TBL] [Abstract][Full Text] [Related]
10. In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells.
Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4594-9. PubMed ID: 16303954
[TBL] [Abstract][Full Text] [Related]
11. Sodium perbarate and benzalkonium chloride induce DNA damage in Chang conjunctival epithelial cells.
Zhang H; Wu H; Yang J; Ye J
Cutan Ocul Toxicol; 2017 Dec; 36(4):336-342. PubMed ID: 28166658
[TBL] [Abstract][Full Text] [Related]
12. Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2011 Jun; 28(6):501-10. PubMed ID: 21603985
[TBL] [Abstract][Full Text] [Related]
13. Influence of different additives and their concentrations on corneal toxicity and antimicrobial effect of benzalkonium chloride.
Onizuka N; Uematsu M; Kusano M; Sasaki H; Suzuma K; Kitaoka T
Cornea; 2014 May; 33(5):521-6. PubMed ID: 24619166
[TBL] [Abstract][Full Text] [Related]
14. In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.
Baudouin C; Riancho L; Warnet JM; Brignole F
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4123-8. PubMed ID: 17724196
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line.
Brasnu E; Brignole-Baudouin F; Riancho L; Guenoun JM; Warnet JM; Baudouin C
Curr Eye Res; 2008 Apr; 33(4):303-12. PubMed ID: 18398704
[TBL] [Abstract][Full Text] [Related]
16. In vitro assessment of the cytotoxicity of anti-allergic eye drops using 5 cultured corneal and conjunctival cell lines.
Ayaki M; Iwasawa A; Yaguchi S; Koide R
J Oleo Sci; 2011; 60(3):139-44. PubMed ID: 21343662
[TBL] [Abstract][Full Text] [Related]
17. N-hydroxymethylglycinate with EDTA is an efficient eye drop preservative with very low toxicity: an in vitro comparative study.
Cristaldi M; Olivieri M; Lupo G; Anfuso CD; Pezzino S; Rusciano D
Cutan Ocul Toxicol; 2018 Mar; 37(1):71-76. PubMed ID: 28658977
[TBL] [Abstract][Full Text] [Related]
18. Toxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells.
De Saint Jean M; Debbasch C; Brignole F; Rat P; Warnet JM; Baudouin C
Curr Eye Res; 2000 Feb; 20(2):85-94. PubMed ID: 10617908
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone eye drop-induced cytotoxicity: role of preservative in P2X7 cell death receptor activation and apoptosis.
Dutot M; Pouzaud F; Larosche I; Brignole-Baudouin F; Warnet JM; Rat P
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2812-9. PubMed ID: 16799018
[TBL] [Abstract][Full Text] [Related]
20. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.
Liang H; Brignole-Baudouin F; Riancho L; Baudouin C
Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
